Structure Therapeutics Inc. (GPCR) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Structure Therapeutics In...

    NASDAQ: GPCR · Real-Time Price · USD
    25.00
    0.01 (0.04%)
    At close: Sep 26, 2025, 3:59 PM
    24.80
    -0.80%
    After-hours: Sep 26, 2025, 07:26 PM EDT

    Structure Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 2.6M 949.17K 623.26K 266.35K
    Gross Profit
    		 -2.6M -949.17K -623.26K -266.35K
    Operating Income
    		 -158.23M -102.78M -52.56M -37.7M
    Interest Income
    		 36.03M 13.38M 1.26M 122.00
    Pretax Income
    		 -122.22M -89.38M -51.3M -37.82M
    Net Income
    		 -122.53M -89.62M -51.32M -38.05M
    Selling & General & Admin
    		 49.41M 32.67M 16.37M 8.59K
    Research & Development
    		 108.81M 70.1M 36.19M 29.11K
    Other Expenses
    		 n/a n/a n/a 37.66M
    Operating Expenses
    		 158.23M 102.78M 52.56M 37.7M
    Interest Expense
    		 n/a 13.39M n/a 122.16K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 158.23M 102.78M 52.56M 37.7M
    Income Tax Expense
    		 310K 236K 17K 231K
    Shares Outstanding (Basic)
    		 52.64M 36.73M 36.59M 36.59M
    Shares Outstanding (Diluted)
    		 52.64M 36.73M 36.59M 36.59M
    EPS (Basic)
    		 -2.34 -2.43 -1.44 -1.2
    EPS (Diluted)
    		 -2.34 -2.43 -1.44 -1.2
    EBITDA
    		 -158.23M -102.46M -52.28M -37.62M
    EBIT
    		 -158.23M -102.78M -52.56M -37.75M
    Depreciation & Amortization
    		 996K 316K 277K 266.35K

    Add to Watchlist